HYDERABAD/BENGALURU Jan 31 (Reuters) - Sun

Pharmaceutical, India's largest drugmaker by revenue,

reported a bigger-than-expected quarterly profit on Friday,

aided by strong sales in the domestic market.

The Mumbai-based firm's consolidated net profit rose 15% to

29.03 billion rupees ($335.3 million) in third quarter, beating

analysts' average estimate of 28.81 billion rupees, according to

data compiled by LSEG.

($1 = 86.5860 Indian rupees)